Primary Site >> Esophagus Cancer
Gene >> RAB3D
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Polymorphisms in DNA repair genes and associations with cancer risk. PMID: 12496039 |
Ref: Searching the MEDLINE literature database through PubMed: a short guide. PMID: 16186693 |
Ref: Radiation therapy and combined modality treatment of gastrointestinal carcinomas. PMID: 16524667 |
Ref: Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma. PMID: 19930599 |
Ref: Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. PMID: 22776426 Ref: Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial). PMID: 23199187 |
Ref: Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial. PMID: 22887465 Ref: A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. PMID: 23975663 |
Ref: Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer. PMID: 23613128 Ref: Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trial. PMID: 23849811 Ref: Evaluation of quality of life following placement of self-expanding plastic stents as a bridge to surgery in patients receiving neoadjuvant therapy for esophageal cancer. PMID: 24567281 Ref: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients. PMID: 24708624 |
Ref: Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial. PMID: 25575640 Ref: Effects on heart function of neoadjuvant chemotherapy and chemoradiotherapy in patients with cancer in the esophagus or gastroesophageal junction - a prospective cohort pilot study within a randomized clinical trial. PMID: 25582305 Ref: Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes. PMID: 25617915 Ref: Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial. PMID: 25650816 Ref: Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. PMID: 25694417 Ref: Health-related quality of life and hospital costs following esophageal resection: a prospective cohort study. PMID: 26338109 |
Ref: Phase I study of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in Japanese patients. PMID: 26991823 Ref: A phase I dose escalation study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer. PMID: 27076940 Ref: A Meta-Analysis and Systematic Review on the Association between Human Papillomavirus (Types 16 and 18) Infection and Esophageal Cancer Worldwide. PMID: 27409078 Ref: Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer. PMID: 27412386 Ref: Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis. PMID: 27826201 |
Ref: Risks and Benefits of Multimodal Esophageal Cancer Treatments: A Meta-Analysis. PMID: 28214903 Ref: Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial. PMID: 28687830 Ref: Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE). PMID: 28705182 Ref: Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis. PMID: 29933436 |
Ref: The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers. PMID: 29409462 Ref: A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol. PMID: 29482649 Ref: Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials. PMID: 29789277 Ref: Health-related quality of life among rural residents aged 45-69 years in Hua County, Henan Province, China: Results of ESECC Trial for esophageal cancer screening with endoscopy. PMID: 29861609 Ref: Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy. PMID: 29933761 Ref: Assessment of graft perfusion and oxygenation for improved outcome in esophageal cancer surgery: Protocol for a single-center prospective observational study. PMID: 30235661 Ref: Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study. PMID: 30342494 |